The TH2 cytokine interleukin-4 (IL-4), which has been reported to regulate FAAH and CB1 receptors in lymphocytes and Jurkat cells [26]–[28], is involved the pathogenesis of several cancer types, including prostate cancer (see [29]–[35]). Here, IL4 is linked to prostate carcinoma.